421 related articles for article (PubMed ID: 25402849)
1. Protein prenylation: enzymes, therapeutics, and biotechnology applications.
Palsuledesai CC; Distefano MD
ACS Chem Biol; 2015 Jan; 10(1):51-62. PubMed ID: 25402849
[TBL] [Abstract][Full Text] [Related]
2. Using inhibitors of prenylation to block localization and transforming activity.
Berzat AC; Brady DC; Fiordalisi JJ; Cox AD
Methods Enzymol; 2006; 407():575-97. PubMed ID: 16757354
[TBL] [Abstract][Full Text] [Related]
3. Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization.
Marchwicka A; Kamińska D; Monirialamdari M; Błażewska KM; Gendaszewska-Darmach E
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628237
[TBL] [Abstract][Full Text] [Related]
4. Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential.
Brioschi M; Martinez Fernandez A; Banfi C
Expert Rev Proteomics; 2017 Jun; 14(6):515-528. PubMed ID: 28521569
[TBL] [Abstract][Full Text] [Related]
5. Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.
Jeong A; Suazo KF; Wood WG; Distefano MD; Li L
Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):279-310. PubMed ID: 29718780
[TBL] [Abstract][Full Text] [Related]
6. Protein prenyltransferases: anchor size, pseudogenes and parasites.
Maurer-Stroh S; Washietl S; Eisenhaber F
Biol Chem; 2003 Jul; 384(7):977-89. PubMed ID: 12956414
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
[TBL] [Abstract][Full Text] [Related]
8. Caged protein prenyltransferase substrates: tools for understanding protein prenylation.
DeGraw AJ; Hast MA; Xu J; Mullen D; Beese LS; Barany G; Distefano MD
Chem Biol Drug Des; 2008 Sep; 72(3):171-81. PubMed ID: 18844669
[TBL] [Abstract][Full Text] [Related]
9. Structure, catalysis, and inhibition mechanism of prenyltransferase.
Chang HY; Cheng TH; Wang AH
IUBMB Life; 2021 Jan; 73(1):40-63. PubMed ID: 33246356
[TBL] [Abstract][Full Text] [Related]
10. Novel prenyltransferase enzymes as a tool for flavonoid prenylation.
Botta B; Delle Monache G; Menendez P; Boffi A
Trends Pharmacol Sci; 2005 Dec; 26(12):606-8. PubMed ID: 16229901
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.
Haney SL; Wills VS; Wiemer DF; Holstein SA
Molecules; 2017 May; 22(6):. PubMed ID: 28555000
[TBL] [Abstract][Full Text] [Related]
12. Use of synthetic isoprenoid analogues for understanding protein prenyltransferase mechanism and structure.
Kale TA; Hsieh SA; Rose MW; Distefano MD
Curr Top Med Chem; 2003; 3(10):1043-74. PubMed ID: 12769708
[TBL] [Abstract][Full Text] [Related]
13. Protein prenylation: unique fats make their mark on biology.
Wang M; Casey PJ
Nat Rev Mol Cell Biol; 2016 Feb; 17(2):110-22. PubMed ID: 26790532
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics.
Cohen LH; Pieterman E; van Leeuwen RE; Overhand M; Burm BE; van der Marel GA; van Boom JH
Biochem Pharmacol; 2000 Oct; 60(8):1061-8. PubMed ID: 11007942
[TBL] [Abstract][Full Text] [Related]
15. Identification and specificity profiling of protein prenyltransferase inhibitors using new fluorescent phosphoisoprenoids.
Dursina B; Reents R; Delon C; Wu Y; Kulharia M; Thutewohl M; Veligodsky A; Kalinin A; Evstifeev V; Ciobanu D; Szedlacsek SE; Waldmann H; Goody RS; Alexandrov K
J Am Chem Soc; 2006 Mar; 128(9):2822-35. PubMed ID: 16506760
[TBL] [Abstract][Full Text] [Related]
16. Rational design of Ras prenyltransferase inhibitors as potential anticancer drugs.
Sebti SM; Hamilton AD
Biochem Soc Trans; 1996 Aug; 24(3):692-9. PubMed ID: 8878828
[No Abstract] [Full Text] [Related]
17. Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.
Lerner EC; Hamilton AD; Sebti SM
Anticancer Drug Des; 1997 Jun; 12(4):229-38. PubMed ID: 9199657
[TBL] [Abstract][Full Text] [Related]
18. Diversity of ABBA Prenyltransferases in Marine Streptomyces sp. CNQ-509: Promiscuous Enzymes for the Biosynthesis of Mixed Terpenoid Compounds.
Leipoldt F; Zeyhle P; Kulik A; Kalinowski J; Heide L; Kaysser L
PLoS One; 2015; 10(12):e0143237. PubMed ID: 26659564
[TBL] [Abstract][Full Text] [Related]
19. Protein prenylation in eukaryotic microorganisms: genetics, biology and biochemistry.
Omer CA; Gibbs JB
Mol Microbiol; 1994 Jan; 11(2):219-25. PubMed ID: 8170384
[TBL] [Abstract][Full Text] [Related]
20. Development of inhibitors of protein farnesylation as potential chemotherapeutic agents.
Kohl NE; Conner MW; Gibbs JB; Graham SL; Hartman GD; Oliff A
J Cell Biochem Suppl; 1995; 22():145-50. PubMed ID: 8538192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]